The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
Open accessAbstract
Background: Long-COVID refers to a variety of symptoms affecting different organs reported by people following Coronavirus Disease 2019 (COVID-19) infection. To date, there have been no robust estimates of the incidence and co-occurrence of long-COVID features, their relationship to age, sex, or severity of infection, and the extent to which they are specific to COVID-19. The aim of this study is to address these issues. Methods and findings: We conducted a retrospective cohort study based on linked electronic health records (EHRs) data from 81 million patients including 273,618 COVID-19 survivors. The incidence and co-occurrence within 6 months and in the 3 to 6 months after COVID-19 diagnosis were calculated for 9 core features of long-COVID (breathing difficulties/breathlessness, fatigue/malaise, chest/throat pain, headache, abdominal symptoms, myalgia, other pain, cognitive symptoms, and anxiety/depression). Their co-occurrence network was also analyzed. Comparison with a propensity score–matched cohort of patients diagnosed with influenza during the same time period was achieved using Kaplan–Meier analysis and the Cox proportional hazard model. The incidence of atopic dermatitis was used as a negative control. Among COVID-19 survivors (mean [SD] age: 46.3 [19.8], 55.6% female), 57.00% had one or more long-COVID feature recorded during the whole 6-month period (i.e., including the acute phase), and 36.55% between 3 and 6 months. The incidence of each feature was: abnormal breathing (18.71% in the 1- to 180-day period; 7.94% in the 90- to180-day period), fatigue/malaise (12.82%; 5.87%), chest/throat pain (12.60%; 5.71%), headache (8.67%; 4.63%), other pain (11.60%; 7.19%), abdominal symptoms (15.58%; 8.29%), myalgia (3.24%; 1.54%), cognitive symptoms (7.88%; 3.95%), and anxiety/depression (22.82%; 15.49%). All 9 features were more frequently reported after COVID-19 than after influenza (with an overall excess incidence of 16.60% and hazard ratios between 1.44 and 2.04, all p < 0.001), co-occurred more commonly, and formed a more interconnected network. Significant differences in incidence and co-occurrence were associated with sex, age, and illness severity. Besides the limitations inherent to EHR data, limitations of this study include that (i) the findings do not generalize to patients who have had COVID-19 but were not diagnosed, nor to patients who do not seek or receive medical attention when experiencing symptoms of long-COVID; (ii) the findings say nothing about the persistence of the clinical features; and (iii) the difference between cohorts might be affected by one cohort seeking or receiving more medical attention for their symptoms. Conclusions: Long-COVID clinical features occurred and co-occurred frequently and showed some specificity to COVID-19, though they were also observed after influenza. Different long-COVID clinical profiles were observed based on demographics and illness severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedThe central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Measures of the Amount of Ecologic Association Between Species
Dice, L. R. (1945) · Ecology · doi:10.2307/1932409 · Cited by 11,874
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · cited 1×
“hospitalization; (7) patients requiring versus not requiring intensive treatment unit (ITU) care; and (8) patients with versus without leukocytosis (defined as a leukocyte count over 11,000 per microliter) [24].”
BackgroundThe trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
The architecture of complex weighted networks
Barrat, A., Barthélemy, M., Pastor-Satorras, R., & Vespignani, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400087101 · Cited by 4,218
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
Attributes and predictors of long COVID
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189 · cited 9×
“The study protocol (not included in the supporting information), including cohorts definition, covariates, and outcomes, was planned before it was executed and almost exactly followed the protocol used in previous studies based on the same dataset (except for the outcomes that are specific to this study) [13,15].”
BackgroundMethodResultInfluentialSelf-citationManagement of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Royston, P., & Parmar, M. K. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,529
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“Another report, based on EHRs from American veterans (88% male) has also identified increased rates of sequelae in multiple body systems after COVID-19 compared to influenza [14].”
BackgroundTaquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484 · cited 1×
“The study protocol (not included in the supporting information), including cohorts definition, covariates, and outcomes, was planned before it was executed and almost exactly followed the protocol used in previous studies based on the same dataset (except for the outcomes that are specific to this study) [13,15].”
MethodSelf-citationHow and why patients made Long Covid
Callard, F., & Perego, E. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113426 · Cited by 924
Haukoos, J. S., & Lewis, R. J. (2015) · JAMA · doi:10.1001/jama.2015.13480 · Cited by 841
Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies
Dani, M., Dirksen, A., Taraborrelli, P., Torocastro, M., Panagopoulos, D., Sutton, R., & Lim, P. B. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0896 · Cited by 721
Long-term Health Consequences of COVID-19
del Rio, C., Collins, L. F., & Malani, P. (2020) · JAMA · doi:10.1001/jama.2020.19719 · Cited by 711
Cognitive deficits in people who have recovered from COVID-19
Hampshire, A., Trender, W., Chamberlain, S. R., Jolly, A. E., Grant, J. E., Patrick, F., Mazibuko, N., Williams, S. C., Barnby, J. M., Hellyer, P., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101044 · Cited by 701
Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L., & Greenhalgh, T. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-06001-y · Cited by 669
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Shah, W., Hillman, T., Playford, E. D., & Hishmeh, L. (2021) · BMJ · doi:10.1136/bmj.n136 · Cited by 631
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
The Writing Committee for the COMEBAC Study Group, Morin, L., Savale, L., Pham, T., Colle, R., Figueiredo, S., Harrois, A., Gasnier, M., Lecoq, A.-L., Meyrignac, O., et al. (2021) · JAMA · doi:10.1001/jama.2021.3331 · Cited by 601
de Lusignan, S., Dorward, J., Correa, A., Jones, N., Akinyemi, O., Amirthalingam, G., Andrews, N., Byford, R., Dabrera, G., Elliot, A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30371-6 · Cited by 593
Using electronic health records for population health research: a review of methods and applications
Casey, J. A., Schwartz, B. S., Stewart, W. F., & Adler, N. E. (2016) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-032315-021353 · Cited by 590
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 435
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2020) · medRxiv · doi:10.1101/2020.12.24.20248802 · Cited by 387
Lancet, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32662-3 · Cited by 251
Long COVID guidelines need to reflect lived experience
Gorna, R., MacDermott, N. E., Rayner, C. R., O’Hara, M. E., Evans, S. E., Agyen, L., Nutland, W., Rogers, N., & Hastie, C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32705-7 · Cited by 153
Neuropsychiatric complications of covid-19
Butler, M., Pollak, T. A., Rooney, A. G., Michael, B. D., & Nicholson, T. R. (2020) · BMJ · doi:10.1136/bmj.m3871 · Cited by 85
Meeting the challenge of long COVID
(2020) · Nature Medicine · doi:10.1038/s41591-020-01177-6 · Cited by 75
Decoding the unknowns in long covid
Altmann, D. M., & Boyton, R. J. (2021) · BMJ · doi:10.1136/bmj.n132 · Cited by 71
Cited by
Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac136 · Cited by 1,366
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
“Our study focused on PASC at 2–3 months post the onset of COVID-19 and thus cannot discern which patients will develop long-term chronic PASC (Taquet et al., 2021).”
Symptoms and risk factors for long COVID in non-hospitalized adults
Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P., Williams, T., Gokhale, K. M., Taverner, T., Chandan, J. S., Brown, K., Simms-Williams, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01909-w · Cited by 1,065
Long COVID after breakthrough SARS-CoV-2 infection
Al-Aly, Z., Bowe, B., & Xie, Y. (2022) · Nature Medicine · doi:10.1038/s41591-022-01840-0 · Cited by 866
A global federated real-world data and analytics platform for research
Palchuk, M. B., London, J. W., Perez-Rey, D., Drebert, Z. J., Winer-Jones, J. P., Thompson, C. N., Esposito, J., & Claerhout, B. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad035 · Cited by 948
Metadata
- Authors
- Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-09-28
- Volume
- 18
- Issue
- 9
- Pages
- e1003773
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W3202014360
- Cited by
- 927
- References
- 32
- FWCI
- 82.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.